VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 29, 2017) - AsiaBaseMetals Inc. (the "Company") (TSX VENTURE:ABZ) is pleased to announce that it has appointed Mr. Sorin Posescu to the Advisory Board of the Company. Mr. Sorin Posescu is a professional geologist having more than 20 years of e...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 19, 2017) - AsiaBaseMetals Inc. (the "Company") (TSX VENTURE:ABZ) is pleased to announce that it has appointed Mr. Bruce Bragagnolo to the Advisory Board of the Company. Mr. Bragagnolo is the co-founder and former Chief Executiv...Read More
TORONTO, ONTARIO--(Marketwired - May 10, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") is very pleased to announce that Mr. Renaud Adams, P. Eng will stand for election to the Company's Board of Directors at the upcoming Annual and Specia...Read More
COPENHAGEN, Denmark, May 11, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live web...Read More
TORONTO, ONTARIO--(Marketwired - May 16, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") is very pleased to announce that Mr. Guillermo Kaelin will stand for election to the Company's Board of Directors at the upcoming Annual and Special Me...Read More
COPENHAGEN, Denmark, May 23, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced financial results for the quarter ended March 31, 2017....Read More
EL MOCHITO, HONDURAS--(Marketwired - June 12, 2017) - Low availability and utilization rates for aging mobile equipment impacted production; new equipment arrivals currently underway Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") announces...Read More
TORONTO, ONTARIO--(Marketwired - Sept. 14, 2016) - Apogee Silver Ltd. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that it has changed its name to Apogee Opportunities Inc. effective September 16, 2016. The Company will continue to trade on the TSX Venture Exchange un...Read More
TORONTO, ONTARIO--(Marketwired - Sep 14, 2016) - Apogee Silver Ltd. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that it has changed its name to Apogee Opportunities Inc. effective September 16, 2016. The Company will continue to trade on the TSX Venture Exchange under the symbol...Read More
TORONTO, ONTARIO--(Marketwired - Oct. 13, 2016) - Apogee Opportunities Inc. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that Mr. Francois Perron has stepped down from the Board of Directors of the Company to focus on other endeavours. Fred Leigh, CEO and Director of...Read More
TORONTO, ONTARIO--(Marketwired - Oct 13, 2016) - Apogee Opportunities Inc. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that Mr. Francois Perron has stepped down from the Board of Directors of the Company to focus on other endeavours. Fred Leigh, CEO and Director of the Company,...Read More
ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the year ended December 31, 2016. Fourth quarter and subsequent operational highlight...Read More
(TheNewswire) Toronto, ON / TheNewswire / April 21, 2017 - At the request of IIROC, Alturas Minerals Corp. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Alturas Mine...Read More
GAITHERSBURG, Md., May04, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the combined company was renamed Altimmune, Inc., and will commence trading on The NASDAQ C...Read More
GAITHERSBURG, Md., May16, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.Dr. Tasker joined the company in April 2016 as Senior Vice Presid...Read More